Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NVO compared with IQV: revenue, margins and what each company keeps, and the suppliers and customers both name
NVO
Novo Nordisk A S
Change
Mkt cap
Revenue
Revenue
IQV
Iqvia Holdings Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
NVO
Novo Nordisk A S
vs
IQV
Iqvia Holdings Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
NVO
No earnings history for NVO.
IQV
3 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±9.1%
▼
−0.75%
×0.09
Q2 FY26
±9.6%
▲
+13.94%
×1.45
Q1 FY26
±8.1%
▲
+9.62%
×1.19
Feb 5 '26
±6.8%
▼
−10.65%
×1.57
= implied
NVO realized, solid
IQV realized, hatched
One scale, both sides: full bar = 14%
× = |realized| ÷ implied
Source: market data
NVO
Novo Nordisk A S
Change
39.98
▲
+2.15%
· post 39.94
Mkt cap
$178.6B
Revenue
—
Revenue
—
IQV
Iqvia Holdings Inc.
Change
266.82
▼
−3.00%
· post 267.50
Closed
Oct 30 '26
Mkt cap
$44.1B
Revenue
$4.4B
Q3 FY26
Revenue
$16.3B
FY25
vs
Compare
Closed
Oct 30 '26
NVO
Novo Nordisk A S
vs
IQV
Iqvia Holdings Inc.
39.98
▲
+2.15%
post 39.94
Price
266.82
▼
−3.00%
post 267.50
$178.6B
Mkt cap
$44.1B
—
Revenue
$4.4B
Q3 FY26
—
Revenue
$16.3B
FY25
Change
Change
NVO
39.98
▲
+2.15%
vs
IQV
266.82
▼
−3.00%
Closed
Oct 30 '26